Company
INCENDIA THERAPEUTICS
Breaking Barriers to Better Cancer Treatment
Also known as Incendia Therapeutics, Inc.
- Status
- Operatingas of 2026-09-17Source (opens in a new tab)
- Business model
- B2B
- Legal name
- Incendia Therapeutics, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
Incendia Therapeutics is a clinical-stage biotechnology company discovering and developing novel monoclonal antibody therapies that disrupt the tumor microenvironment (TME) to improve outcomes in cancer treatment.
Products
- Other
- PRTH-101
Loading relationship preview